Form 4: Glaukos Director Sells Shares After Option Exercise
Insider Transaction Report
Glaukos Corp. Director Gilbert H. Kliman exercised stock options and subsequently sold an equal number of common shares on December 9, 2025, under a Rule 10b5-1 plan.
Summary
- Gilbert H. Kliman, a Director of Glaukos Corp (GKOS), engaged in transactions involving the company's common stock.
- On December 9, 2025, Kliman acquired 5,000 shares of common stock through the exercise of a stock option at a price of $24.69 per share.
- Immediately following the option exercise on the same date, Kliman sold 5,000 shares of common stock at a weighted average price of $107.27 per share.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan, which was checked on the filing.
- After these transactions, Kliman's direct beneficial ownership of common stock decreased from 39,905 shares to 34,905 shares.
- The remaining stock options beneficially owned by Kliman are 10,000, with an exercise price of $24.69 and an expiration date of June 2, 2026.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction where a director exercised stock options and immediately sold the acquired shares under a pre-arranged 10b5-1 plan. While the sale reduces direct beneficial ownership, it's a common practice for insiders to monetize vested options, especially given the significant profit margin between the exercise and sale price. This type of transaction is generally neutral in terms of company-specific sentiment unless it signals a broader pattern of insider selling.
Positives
- A director exercised stock options, indicating value in the underlying stock at the exercise price of $24.69.
- The sale price of $107.27 per share is significantly higher than the exercise price of $24.69, indicating a substantial profit for the director on the exercised shares.
Negatives
- A director sold 5,000 shares of common stock, reducing their direct beneficial ownership.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reported transactions were executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities. | Prior to 12/09/2025 | Rule 10b5-1 plans allow insiders to pre-arrange trades to avoid accusations of trading on material non-public information, enhancing transparency and compliance with insider trading regulations. |
Related Party Transactions
- Gilbert H. Kliman, a Director of Glaukos Corp, engaged in the exercise of stock options and subsequent sale of common stock.
Stakeholder Impact
- Shareholders: The sale by a director could be perceived as a slight negative, but the pre-planned nature (10b5-1) mitigates concerns about opportunistic selling. The significant profit realized by the director highlights the stock's appreciation over the option's life.
Key Dates
| Date | Description |
|---|---|
| 06/02/2016 | Grant date of the stock option. |
| 06/02/2017 | Date the stock option fully vested (first anniversary of grant date). |
| 12/09/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 12/11/2025 | Signature date of the reporting person's attorney-in-fact. |
| 06/02/2026 | Expiration date of the stock option. |
Recommendation
holdThis Form 4 reports a routine, pre-planned insider transaction (exercise of options and sale of shares) by a director. Such transactions are common for insiders to diversify holdings or realize gains from vested options. While a sale by a director might be viewed cautiously, the fact that it was executed under a Rule 10b5-1 plan suggests it was not based on new material non-public information. The transaction itself does not provide new fundamental information about the company's operations or future prospects to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions while awaiting more substantive company news.
Keywords
Glaukos Corp, GKOS, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Director Transaction, Rule 10b5-1, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.